TPCH
Welcome,         Profile    Billing    Logout  
 6 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chambers, Daniel
ALLELE, NCT03394365 / 2017-002949-30: Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy

Checkmark Data from ALLELE trial for post-transplant lymphoproliferative disease
Dec 2021 - Dec 2021: Data from ALLELE trial for post-transplant lymphoproliferative disease
Recruiting
3
66
Europe, Canada, US, RoW
tabelecleucel, tab-cel®, ATA129, EBV-CTL
Atara Biotherapeutics
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant, Stem Cell Transplant Complications
08/25
06/27
TETON-2, NCT05255991 / 2021-005881-17: Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Active, not recruiting
3
597
Europe, RoW
Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer
United Therapeutics
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
07/25
07/25
SiroSkin, NCT05860881: Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients

Recruiting
3
146
RoW
Sirolimus Topical Cream, Rapamycin, Placebo, Vehicle alone
Melanoma and Skin Cancer Trials Limited, Monash University, The University of Queensland
Solid Organ Transplant Recipients, Skin Cancer
05/26
12/26
SPARTA, NCT01983241 / 2013-001870-38: Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)

Active, not recruiting
3
345
Europe, Canada, US, RoW
Alpha-1 MP, Prolastin-C, 0.9% Sodium Chloride for Injection, USP, Saline
Grifols Therapeutics LLC
Pulmonary Emphysema in Alpha-1 PI Deficiency
08/26
01/27
ASSIST-CLAD, NCT02709343: Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction

Completed
2
64
RoW
Bone-marrow derived MSCs, MSC, Placebo
The University of Queensland, Isopogen, Cell and Tissue Therapies
Chronic Lung Allograft Dysfunction (CLAD)
09/23
10/23
ELEVAATE, NCT05856331: Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

Active, not recruiting
2
99
Europe, US, RoW
SAR447537, Zemaira, Respreeza
Sanofi
Alpha 1-Antitrypsin Deficiency, Emphysema
08/25
10/25
SHIELD, NCT05402176: The Whole Lung Lavage Study

Not yet recruiting
N/A
30
RoW
Whole Lung Lavage
The University of Queensland
Silicosis
06/24
12/24
SHIELD, NCT05546944: The Study-silicosis

Recruiting
N/A
120
RoW
The University of Queensland, The Prince Charles Hospital, Royal Prince Alfred Hospital, Sydney, Australia, The Alfred, Austin Hospital, Melbourne Australia
Silicosis
06/24
12/24
Chambers
No trials found

Download Options